Seeking Alpha

Questcor Pharmaceuticals (QCOR +10.1%) jumps after releasing June prescription data for its...

Questcor Pharmaceuticals (QCOR +10.1%) jumps after releasing June prescription data for its Acthar gel. Paid Acthar prescriptions for treating nephrotic syndrome rose to 115-120 in June from 103 in May, prescriptions for treating multiple sclerosis rose to 400-410 from 365, and prescriptions for treating infantile spasms came in at 30-35, compared with 32 in May. It's added Questcor repurchased $156.1M worth of shares in Q2 at an average price of $41.85.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|